Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 September 2018 Photo Thabo Kessah
Burnout affects productivity in higher education
Elizabeth Nchapi’s study says burnout has adverse results for both employer and employee.

Staff members who are chronically exhausted may develop a cynical attitude towards their work and are likely to underperform, therefore feeling incompetent or experiencing a sense of reduced accomplishment. This is according to a research study by Elizabeth Nchapi, Head: Finances, on the University of the Free State’s Qwaqwa Campus. The study, which formed part of her Master of Arts (Higher Education Studies), also gives a comprehensive view on potential consequences for individuals and the organisation itself.

“The study was informed by my experience as a finance professional working at a higher-education institution where most of the research on burnout has mainly been around academic staff, hence this study focused on administrative staff,” she said.

Work environment stressors for administration staff

“Administrative staff in this sector have a responsibility to provide quality service not only to the academic core business of the institution, but also to the external stakeholders. Their working conditions require extensive multitasking, as they may often be expected to perform external roles or in fields other than their regular functions. Given that they continuously work under these circumstances, members may increasingly suffer from pressure leading to stress and burnout, which is a state of mental and physical exhaustion caused by one’s work environment.”

Work-environment stressors that lead to burnout, according to the study, include work overload, student interaction, team conflict, role ambiguity, job insecurity, lack of organisational support, lack of motivation, and workplace bullying.

Results of burnout

“Some of the potential consequences of burnout that have been identified as serious health problems may include, among others, sleep disturbances, anxiety, depression, and respiratory infections,” said Nchapi.

“Previous studies have shown that burnout does not only impact employees’ physical and psychological well-being. It also has significant consequences for the organisations and the employers. These include absenteeism, alcohol abuse, and poor organisational commitment, which ultimately result in poor performance,” she added.

The study further emphasises that personal and organisational consequences cut across the lines of gender, age, race, and employment levels. 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept